Organization
AnHeart Therapeutics
5 clinical trials
Clinical trial
A Phase I, Multi-center, Open-label, Single-arm Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of AB-218 for Treating Adult Patients With Advanced IDH1 Mutant Cholangiocarcinoma and Other Solid TumorsStatus: Recruiting, Estimated PCD: 2025-08-01
Clinical trial
A Single-Arm, Open-Label, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of Taletrectinib in Patients With Advanced or Metastatic ROS1 Positive NSCLC and Other Solid TumorsStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
A Phase I, Single-center, Open-label, Fixed Sequence Study in Chinese Healthy Male Adults to Evaluate the Effect of Omeprazole on the Pharmacokinetics of AB-106Status: Completed, Estimated PCD: 2023-01-20
Clinical trial
A Phase 2, Multicenter, Open Label, Two Parts Clinical Study to Evaluate the Efficacy and Safety of Safusidenib Erbumine in Patients With Isocitrate Dehydrogenase 1 (IDH1) Mutant GliomaStatus: Recruiting, Estimated PCD: 2027-03-31
Clinical trial
A Multicenter, Open Label, Single Arm Phase 2 Study of AB-106 in the Treatment of Locally Advanced and Metastatic NSCLCStatus: Active (not recruiting), Estimated PCD: 2023-12-30